Safety and Efficacy of Loco-regional B7H3 IL-7Ra CAR T Cell in DIPG
Condition(s):DIPG Brain Tumor; Diffuse Intrinsic Pontine GliomaLast Updated:January 24, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):DIPG Brain Tumor; Diffuse Intrinsic Pontine GliomaLast Updated:January 24, 2024Not yet recruiting
Condition(s):Brain and Nervous SystemLast Updated:February 28, 2024Recruiting
Condition(s):Central Nervous System Tumor; Diffuse Intrinsic Pontine Glioma; Diffuse Midline Glioma; Ependymoma; Medulloblastoma, Childhood; Germ Cell Tumor; Atypical Teratoid/Rhabdoid Tumor; Primitive Neuroectodermal Tumor; Choroid Plexus Carcinoma; Pineoblastoma, Childhood; GliomaLast Updated:December 20, 2023Recruiting
Condition(s):Recurrent Glioblastoma; Refractory GlioblastomaLast Updated:December 28, 2022Recruiting
Condition(s):Central Nervous System Neoplasms; Atypical Teratoid/Rhabdoid Tumor; Diffuse Midline Glioma, H3 K27M-Mutant; Ependymoma; High Grade Glioma; Glioblastoma; MedulloblastomaLast Updated:March 13, 2024Recruiting
Condition(s):Pancreas Cancer; Relapse; Resistant CancerLast Updated:December 6, 2023Not yet recruiting
Condition(s):Epithelial Ovarian CancerLast Updated:June 18, 2023Recruiting
Condition(s):EGFR/ B7H3-positive Advanced Lung Cancer; EGFR/ B7H3-positive Advanced Triple-negative Breast CancerLast Updated:February 28, 2023Recruiting
Condition(s):Glioblastoma MultiformeLast Updated:October 30, 2023Recruiting
Condition(s):Ovary Neoplasm; Ovarian Cancer; Epithelial Ovarian Cancer; RecurrentLast Updated:March 12, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.